Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Akova

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 5, 2020
Mixed fungaemia: an 18-year report from a tertiary-care university hospital and a systematic reviewD Gülmez, S Alp, G Gursoy, et al.
International Journal of Antimicrobial Agents|November 24, 1999
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of TurkeyM Akova, H Akan, V Korten, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 7, 2017
ESCMID-an international Europe-based society committed to fostering cross-border collaboration and education to improve patient careM Poljak, M Akova, A W Friedrich, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2019
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in ChinaP Zhang, Q Shi, H Hu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1994
Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcomeM Akova, H E Akalin, O Uzun, et al.
Bone Marrow Transplantation|October 29, 2009
Bacterial infection prevention after hematopoietic cell transplantationD Engelhard, M Akova, M J Boeckh, et al.
The Journal of Hospital Infection|February 28, 2012
Laboratory-acquired brucellosis in TurkeyS Sayin-Kutlu, M Kutlu, O Ergonul, et al.
Scandinavian Journal of Infectious Diseases|January 5, 2002
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter studyM Erman, M Akova, H Akan, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1996
Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infectionsM Akova, O Ozcebe, I Güllü, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 27, 2018
ESCMID white paper: a guide on ESCMID guidance documentsL Scudeller, J Rodríguez-Baño, A Zinkernagel, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 5, 2020
Mixed fungaemia: an 18-year report from a tertiary-care university hospital and a systematic reviewD Gülmez, S Alp, G Gursoy, et al.
International Journal of Antimicrobial Agents|November 24, 1999
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of TurkeyM Akova, H Akan, V Korten, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 7, 2017
ESCMID-an international Europe-based society committed to fostering cross-border collaboration and education to improve patient careM Poljak, M Akova, A W Friedrich, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2019
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in ChinaP Zhang, Q Shi, H Hu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1994
Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcomeM Akova, H E Akalin, O Uzun, et al.
Bone Marrow Transplantation|October 29, 2009
Bacterial infection prevention after hematopoietic cell transplantationD Engelhard, M Akova, M J Boeckh, et al.
The Journal of Hospital Infection|February 28, 2012
Laboratory-acquired brucellosis in TurkeyS Sayin-Kutlu, M Kutlu, O Ergonul, et al.
Scandinavian Journal of Infectious Diseases|January 5, 2002
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter studyM Erman, M Akova, H Akan, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1996
Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infectionsM Akova, O Ozcebe, I Güllü, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 27, 2018
ESCMID white paper: a guide on ESCMID guidance documentsL Scudeller, J Rodríguez-Baño, A Zinkernagel, et al.
Pageof 7